Crisis at Syneos Health in Italy: uncertainty for 49 workers
The US multinational Syneos Health, active in the clinical research and pharmaceutical development sector, has announced the layoff of 49 employees at its Italian branch. The news has caused significant concern among workers and union representatives, who are now calling for an urgent meeting to manage the situation.
Currently, the dialogue between the company and the unions is at a standstill. The company employs approximately 319 people in Italy, and the planned cuts would affect a significant portion of the workforce. Social partners are trying to find alternative solutions to prevent the layoffs from becoming final.
The pharmaceutical research sector is very important to the Italian economy, but decisions made by large foreign multinationals can have a direct and heavy impact on local employment. The unions have emphasized the need to protect jobs and evaluate different strategies to address the company's difficulties.
New meetings between worker representatives and Syneos Health management are scheduled for the coming weeks. The main objective is to reduce the number of redundancies and reach an agreement that can safeguard the professional future of the employees involved in this crisis.